GYRE THERAPEUTICS, INC. Common Stock Shares Outstanding

Quick Answer

GYRE THERAPEUTICS, INC. reported Common Stock Shares Outstanding of 91.31 million shares for the year ending 2025.

  • GYRE THERAPEUTICS, INC. showed an increase of +5.8% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from GYRE THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
  • XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 16 years of available data (2010 to 2025), GYRE THERAPEUTICS, INC.'s Common Stock Shares Outstanding has grown by 216.3%.
  • Historical annual values: Fiscal year 2025: 91.31 million shares | Fiscal year 2024: 86.31 million shares | Fiscal year 2023: 76.60 million shares | Fiscal year 2022: 63.59 million shares | Fiscal year 2021: 31.41 million shares | Fiscal year 2020: 22.10 million shares | Fiscal year 2019: 12.04 million shares | Fiscal year 2018: 11.95 million shares | Fiscal year 2017: 6.08 million shares | Fiscal year 2016: 801,756 shares | Fiscal year 2015: 762,005 shares | Fiscal year 2014: 370,944 shares | Fiscal year 2013: 33.72 million shares | Fiscal year 2012: 33.62 million shares | Fiscal year 2011: 33.38 million shares | Fiscal year 2010: 28.87 million shares.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: